您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [citeline]:全球患者洞察用例 - 发现报告

全球患者洞察用例

医药生物 2024-05-15 citeline 匡露
报告封面

Situation A sponsor is planning aPhase II trial evaluating the safety and anti-tumoractivity of an investigational mRNA treatmentin adults who have selectadvanced solid tumor cancerand needs to be able to: Identify investigators across 4 countrieswho can support their study; Understand the investigator’s patient landscape to ensurethey have access to those with these types of tumor cancer; Ensure they are enrolling a wide range of participants in thetrial to make sure the treatment works across ethnicities, races,and genders. Identify investigators across the US, France, Spain,and Germany who have the experience and capacityto deliver on the study.1 Sitetrove helps sponsors select clinical trial investigators and sites basedon geographical locations, past experience, current workload, and patientaccessibility. Once a shortlist of investigators is developed, determinewhich of those investigators has the greatest access topatients who will likely meet the I/E criteria.2 Global Patient Insights helps prioritize countries and global sites with highervolumes of clinically relevant patient populations. Determine which investigator of those with eligiblepatients has the broadest range of patients to ensurerepresentation across ethnicities, races, and genders.3 Global Patient Insights enables sponsors to reach diversity enrollmenttargets with a strong package of diversity insights from real-world andcensus data. Benefits Access an all-in-one solutionfor investigator and patient insights Select sites that have the patients tomeet enrollment goals Easily analyze patient populationsat country, site, and US investigator levels Learn how you can locate sites with clinically relevant anddiverse patient populations with Global Patient Insights. Citeline, aNorstellacompany, powers a full suite ofcomplementary business intelligence offerings to meet theevolving needs of life science professionals to accelerate theconnection of treatments to patients and patients to treatments.These patient-focused solutions and services deliver and analyzedata used to drive clinical, commercial, and regulatory-relateddecisions and create real-world opportunities for growth. Our global teams of analysts, journalists, and consultants keeptheir fingers on the pulse of the pharmaceutical, biomedical,and medtech industries, covering it all with expert insights: keydiseases, clinical trials, drug R&D and approvals, market forecastsand more. For more information on one of the world’s most trustedlife science partners, visitCiteline.com